Drugs / 75 mg/m2 given subcutaneously (SC) or IV x 7 days, every 4 weeks
75 mg/m2 given subcutaneously (SC) or IV x 7 days, every 4 weeks
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02785900 Background | May 2016 → Oct 2017 | acute myeloid leukemia | Seagen Inc. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 75 mg/m2 given subcutaneously (SC) or IV x 7 days, every 4 weeks | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02785900 ↗ |
| Route | Intravenous | “given subcutaneously (SC) or IV” NCT02785900 ↗ |
| Route | Subcutaneous | “given subcutaneously (SC) or IV” NCT02785900 ↗ |